{"entity":{"type":"insider","cik":"0001380762","url":"/insider/0001380762","json_url":"/insider/0001380762.json","name":"Dorsey Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":19,"first":"2007-04-27","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Dorsey Brian","source":"filing","n_filings":19,"first_seen":"2007-04-27","last_seen":"2025-11-14"}],"transactions":[{"id":5152008,"accession":"0001380762-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001380762-25-000005","line_url":"/filing/0001380762-25-000005#line-2","is_derivative":false,"issuer_cik":"0001380762","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001380762","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21828.0,"shares_display":"21,828","price_per_share":8.7067,"price_display":"8.71","price_state":"stated","total_value":190049.8476,"total_display":"190,049.85","total_whole":"190,050","shares_owned_after":10789.0,"shares_owned_after_display":"10,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":2157317,"accession":"0001415889-24-029376","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-029376","line_url":"/filing/0001415889-24-029376#line-4","is_derivative":false,"issuer_cik":"0001380762","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001380762","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.2973,"price_display":"12.30","price_state":"stated","total_value":307432.5,"total_display":"307,432.50","total_whole":"307,433","shares_owned_after":6024.0,"shares_owned_after_display":"6,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-12","filed_date":"2024-12-13","scope":"insider"},{"id":2157312,"accession":"0001415889-24-029376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029376","line_url":"/filing/0001415889-24-029376#line-2","is_derivative":false,"issuer_cik":"0001380762","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001380762","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":12.4284,"price_display":"12.43","price_state":"stated","total_value":186426.0,"total_display":"186,426.00","total_whole":"186,426","shares_owned_after":6024.0,"shares_owned_after_display":"6,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider"},{"id":2222966,"accession":"0001415889-24-021886","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021886","line_url":"/filing/0001415889-24-021886#line-2","is_derivative":false,"issuer_cik":"0001380762","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001380762","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":6024.0,"shares_owned_after_display":"6,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-21","scope":"insider"},{"id":2661864,"accession":"0001415889-24-021364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021364","line_url":"/filing/0001415889-24-021364#line-2","is_derivative":false,"issuer_cik":"0001380762","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001380762","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":390000.0,"total_display":"390,000.00","total_whole":"390,000","shares_owned_after":6024.0,"shares_owned_after_display":"6,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":6330946,"accession":"0001017491-14-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001017491-14-000122","line_url":"/filing/0001017491-14-000122#line-1","is_derivative":false,"issuer_cik":"0001017491","issuer_name":"APRICUS BIOSCIENCES, INC.","issuer_ticker":"APRI","issuer_name_source":null,"issuer_url":"/issuer/0001017491","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0481,"price_display":"1.05","price_state":"stated","total_value":10481.0,"total_display":"10,481.00","total_whole":"10,481","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-30","scope":"insider"},{"id":2742168,"accession":"0001209191-12-000915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-000915","line_url":"/filing/0001209191-12-000915#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":0.4766,"price_display":"0.48","price_state":"stated","total_value":4289.4,"total_display":"4,289.40","total_whole":"4,289","shares_owned_after":134452.0,"shares_owned_after_display":"134,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":7306561,"accession":"0001209191-10-058421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-058421","line_url":"/filing/0001209191-10-058421#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8468.0,"shares_display":"8,468","price_per_share":2.6839,"price_display":"2.68","price_state":"stated","total_value":22727.2652,"total_display":"22,727.27","total_whole":"22,727","shares_owned_after":43452.0,"shares_owned_after_display":"43,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider"},{"id":7393205,"accession":"0001209191-10-045175","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-10-045175","line_url":"/filing/0001209191-10-045175#line-7","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":12810.0,"total_display":"12,810.00","total_whole":"12,810","shares_owned_after":51920.0,"shares_owned_after_display":"51,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-03","scope":"insider"},{"id":7717920,"accession":"0001209191-10-044276","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-044276","line_url":"/filing/0001209191-10-044276#line-3","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":24950.0,"total_display":"24,950.00","total_whole":"24,950","shares_owned_after":51920.0,"shares_owned_after_display":"51,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-25","filed_date":"2010-08-27","scope":"insider"},{"id":7590605,"accession":"0001209191-10-042606","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-10-042606","line_url":"/filing/0001209191-10-042606#line-7","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":11970.0,"total_display":"11,970.00","total_whole":"11,970","shares_owned_after":51920.0,"shares_owned_after_display":"51,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-10","filed_date":"2010-08-13","scope":"insider"},{"id":7162805,"accession":"0001209191-10-038827","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-10-038827","line_url":"/filing/0001209191-10-038827#line-7","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":11970.0,"total_display":"11,970.00","total_whole":"11,970","shares_owned_after":51920.0,"shares_owned_after_display":"51,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-15","filed_date":"2010-07-16","scope":"insider"},{"id":7331375,"accession":"0001209191-10-035772","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-10-035772","line_url":"/filing/0001209191-10-035772","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":4.4829,"price_display":"4.48","price_state":"stated","total_value":40346.1,"total_display":"40,346.10","total_whole":"40,346","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-24","filed_date":"2010-06-25","scope":"insider","n_lines":6},{"id":7589171,"accession":"0001209191-10-018094","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-10-018094","line_url":"/filing/0001209191-10-018094","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70500.0,"shares_display":"70,500","price_per_share":6.695732056737588,"price_display":"6.70","price_state":"stated","total_value":472049.11,"total_display":"472,049.11","total_whole":"472,049","shares_owned_after":44420.0,"shares_owned_after_display":"44,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-18","filed_date":"2010-03-22","scope":"insider","n_lines":9},{"id":7145542,"accession":"0001209191-10-013766","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-10-013766","line_url":"/filing/0001209191-10-013766#line-9","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":4.0078,"price_display":"4.01","price_state":"stated","total_value":92179.4,"total_display":"92,179.40","total_whole":"92,179","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-02","scope":"insider"},{"id":7145532,"accession":"0001209191-10-013766","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-013766","line_url":"/filing/0001209191-10-013766#line-3","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":23940.0,"total_display":"23,940.00","total_whole":"23,940","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-26","filed_date":"2010-03-02","scope":"insider"},{"id":7544490,"accession":"0001209191-10-007984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-007984","line_url":"/filing/0001209191-10-007984#line-4","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20712.0,"shares_display":"20,712","price_per_share":3.0595,"price_display":"3.06","price_state":"stated","total_value":63368.364,"total_display":"63,368.36","total_whole":"63,368","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-05","filed_date":"2010-02-09","scope":"insider"},{"id":7180048,"accession":"0001209191-10-001361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-001361","line_url":"/filing/0001209191-10-001361#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.069,"price_display":"1.07","price_state":"stated","total_value":5345.0,"total_display":"5,345.00","total_whole":"5,345","shares_owned_after":49712.0,"shares_owned_after_display":"49,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-01-05","scope":"insider"},{"id":5826487,"accession":"0001209191-09-024201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-024201","line_url":"/filing/0001209191-09-024201#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":370.0,"total_display":"370.00","total_whole":"370","shares_owned_after":17212.0,"shares_owned_after_display":"17,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-01","filed_date":"2009-05-04","scope":"insider"},{"id":8333543,"accession":"0001209191-07-035038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-035038","line_url":"/filing/0001209191-07-035038#line-3","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-31","filed_date":"2007-06-04","scope":"insider"},{"id":8324948,"accession":"0001209191-07-026054","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-026054","line_url":"/filing/0001209191-07-026054","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":18020.0,"total_display":"18,020.00","total_whole":"18,020","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-27","filed_date":"2007-04-27","scope":"insider","n_lines":2},{"id":8324932,"accession":"0001209191-07-026054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-026054","line_url":"/filing/0001209191-07-026054#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001380762","owner_name":"Dorsey Brian","owner_display_name":"Dorsey Brian","owner_url":"/insider/0001380762","role":"Officer (VP Product Development)","role_mark":"O","role_mark_label":"Officer (VP Product Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Product Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":15.0427,"price_display":"15.04","price_state":"stated","total_value":60170.8,"total_display":"60,170.80","total_whole":"60,171","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-25","filed_date":"2007-04-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Officer (Chief Operating Officer)","n_filings":4,"first_seen":"2024-08-15","last_seen":"2025-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001017491","name":"APRICUS BIOSCIENCES, INC.","url":"/issuer/0001017491","role":"Officer (Chief Development Officer)","n_filings":1,"first_seen":"2014-12-30","last_seen":"2014-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Officer (SVP, Technical Operations)","n_filings":14,"first_seen":"2007-04-27","last_seen":"2012-01-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380762","retrieved_at":"2026-08-27T08:12:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}